EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PARAOXONASE 1 ENZYME ACTIVITY AND MYELOPEROXIDASE CONCENTRATION IN INDIVIDUALS WITH ANGIOGRAPHICALLY CONFIRMED CORONARY ARTERY DISEASE

Katerina Krsteva Jakimovska, Marija Vavlukis, Oliver Bushljetic, Sonja Topuzovska

Academic Medical Journal · 24.03.2026 · 6 (1) · 41-49

DOI: 10.53582/2j2dgz39 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Medical Journal, online erschienen am 24.03.2026. Verfasst von Katerina Krsteva Jakimovska und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

PON1 and MPO are key regulators of HDL function. While PON1 exerts antiatherogenic protection by limiting lipid oxidation, MPO promotes HDL oxidation and the formation of dysfunctional, pro-inflammatory HDL.

Aim

This study aimed to evaluate the relationship between PON1 catalytic activity and MPO concentration with the development and severity of atherosclerosis and coronary artery disease in patients from the Republic of North Macedonia. Material and methods: This cross-sectional study included subjects undergoing percutaneous coronary angiography with or without stenting due to monitoring of stable angina or induced ischemia. The catalytic activity of the PON1 enzyme and the concentration of the MPO enzyme were analyzed. The PON1 catalytic activity was measured spectrophotometrically, MPO levels were measured with a human MPO ELISA test kit.

Results

A total of 165 subjects (106 CAD, 59 non-CAD) were analyzed. CAD patients had significantly lower PON1 activity, whereas MPO levels did not differ. MPO/PON1 ratio and HDL×PON1 index clearly discriminated CAD from non-CAD. CAD patients showed lower HDL and ApoA1 and higher glucose and Lp(a). Across CAD severity stratification (no stent, stent, restenosis), LDL and triglycerides were similar, while Lp(a) increased and HDL×PON1 declined, indicating progressive HDL dysfunction and oxidative imbalance.

Conclusion

Our findings suggest that CAD was associated with lower PON1 activity, reflecting dysfunctional and pro-oxidative HDL despite similar LDL levels. Lp(a) increased with atherosclerosis severity and was highest in patients with restenosis, highlighting the value of combined biochemical testing for enhanced cardiovascular risk stratification and early identification of susceptibility in the Macedonian population.

Zitieren

APA

Jakimovska, K. K., Vavlukis, M., Bushljetic, O., & Topuzovska, S. (2026). PARAOXONASE 1 ENZYME ACTIVITY AND MYELOPEROXIDASE CONCENTRATION IN INDIVIDUALS WITH ANGIOGRAPHICALLY CONFIRMED CORONARY ARTERY DISEASE. Academic Medical Journal, 6(1), 41-49. https://doi.org/10.53582/2j2dgz39

Vancouver

Jakimovska KK, Vavlukis M, Bushljetic O, Topuzovska S. PARAOXONASE 1 ENZYME ACTIVITY AND MYELOPEROXIDASE CONCENTRATION IN INDIVIDUALS WITH ANGIOGRAPHICALLY CONFIRMED CORONARY ARTERY DISEASE. Academic Medical Journal. 2026;6(1):41-49. doi:10.53582/2j2dgz39

BibTeX
@article{Jakimovska2026,
  author = {Jakimovska, Katerina Krsteva and Vavlukis, Marija and Bushljetic, Oliver and Topuzovska, Sonja},
  title = {PARAOXONASE 1 ENZYME ACTIVITY AND MYELOPEROXIDASE CONCENTRATION IN INDIVIDUALS WITH ANGIOGRAPHICALLY CONFIRMED CORONARY ARTERY DISEASE},
  journal = {Academic Medical Journal},
  year = {2026},
  volume = {6},
  number = {1},
  pages = {41--49},
  doi = {10.53582/2j2dgz39}
}
Kostenlos starten →